Literature DB >> 15960638

Comparative evaluation of midazolam and ketamine with midazolam alone as oral premedication.

Babita Ghai1, Radhika Prasad Grandhe, Arun Kumar, Pramila Chari.   

Abstract

BACKGROUND: Oral premedication with midazolam and ketamine is widely used in pediatric anesthesia to reduce emotional trauma and ensure smooth induction. However, various dosing regimens when used alone or in combination have variable efficacy and side effect profile. The aim of our study was to investigate and compare the efficacy of oral midazolam alone with a low-dose combination of oral midazolam and ketamine.
METHODS: We performed a prospective randomized double-blind study in 100 children who were randomly allocated into two groups. Group M received 0.5 mg.kg(-1) oral midazolam and group MK received 0.25 mg.kg(-1) oral midazolam with 2.5 mg.kg(-1) oral ketamine. The preoperative sedation score, ease of parental separation and ease of mask acceptance were evaluated on a 4-point scale. The time to recovery from anesthesia and to achieve satisfactory Aldrete score was also noted.
RESULTS: Uniform and acceptable sedation scores were seen in both the groups (group M 95.9%; group MK 97.96%), without any serious side effects. However, the combination offered significantly more children in an awake, calm and quiet state, who were easily separated from their parents (73.46% in MK vs 41% in group M). The induction scores were comparable between the groups. The recovery room characteristics and time to achieve satisfactory Aldrete score were also comparable between the two groups.
CONCLUSIONS: Oral midazolam alone and a combination of midazolam with ketamine provide equally effective anxiolysis and separation characteristics. However, the combination provided more children in an awake, calm and quiet state who could be separated easily from parents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15960638     DOI: 10.1111/j.1460-9592.2004.01523.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  14 in total

1.  Evaluation of Efficacy of Oral Ketamine and Midazolam Combination Drug in Different Doses in Different Groups Used for Moderate Sedation in Pediatric Dentistry Randomized-comparative Trial.

Authors:  Seema Thakur; Kalpana Verma; Parul Singhal; Deepak Chauhan
Journal:  Int J Clin Pediatr Dent       Date:  2021

2.  Remimazolam induced cognitive dysfunction in mice via glutamate excitotoxicity.

Authors:  Xin-Hua Zhou; Cheng-Cheng Zhang; Ling Wang; Shan-Liang Jin
Journal:  Transl Neurosci       Date:  2022-05-31       Impact factor: 1.264

3.  Surgical management of the patient living with autism.

Authors:  Paige Selvey; Katie Stypulkowski; Steven Waisbren
Journal:  Surg Open Sci       Date:  2019-07-12

4.  Comparative evaluation of midazolam and butorphanol as oral premedication in pediatric patients.

Authors:  Chandni Sinha; Manpreet Kaur; Ajeet Kumar; Anand Kulkarni; M Ambareesha; Madhusudan Upadya
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01

5.  Is premedication with midazolam more effective by the sublingual than the oral route?

Authors:  Shobhana Gupta; Hina Gadani; Shravan Kedia
Journal:  Anesth Essays Res       Date:  2011 Jan-Jun

6.  Comparative evaluation of dexmedetomidine and midazolam-ketamine combination as sedative agents in pediatric dentistry: A double-blinded randomized controlled trial.

Authors:  Parul Uppal Malhotra; Seema Thakur; Parul Singhal; Deepak Chauhan; Cheranjeevi Jayam; Ritu Sood; Yagyeshwar Malhotra
Journal:  Contemp Clin Dent       Date:  2016 Apr-Jun

7.  Comparison of intranasal dexmedetomidine and dexmedetomidine-ketamine for premedication in pediatrics patients: A randomized double-blind study.

Authors:  Ravi Bhat; M C B Santhosh; Venkatesh M Annigeri; Raghavendra P Rao
Journal:  Anesth Essays Res       Date:  2016 May-Aug

8.  Comparison of the effects of intravenous premedication: Midazolam, Ketamine, and combination of both on reducing anxiety in pediatric patients before general anesthesia.

Authors:  Parvin Sajedi; Bashir Habibi
Journal:  J Res Pharm Pract       Date:  2015 Oct-Dec

9.  The interactive effects of ketamine and magnesium upon depressive-like pathology.

Authors:  Sara Razmjou; Darcy Litteljohn; Chris Rudyk; Shuaib Syed; Melanie Clarke; Rowan Pentz; Zach Dwyer; Shawn Hayley
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-08       Impact factor: 2.570

10.  A Comparison of Oral Midazolam-ketamine, Dexmedetomidine-fentanyl, and Dexmedetomidine-ketamine Combinations as Sedative Agents in Pediatric Dentistry: A Triple-Blinded Randomized Controlled Trial.

Authors:  Astha Jaikaria; Seema Thakur; Parul Singhal; Deepak Chauhan; Cheranjeevi Jayam; Kartik Syal
Journal:  Contemp Clin Dent       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.